{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:02:45Z","timestamp":1790049765809,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["phytomedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.phymed.2014.07.011","type":"journal-article","created":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T09:15:45Z","timestamp":1409217345000},"page":"1525-1533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking"],"prefix":"10.1016","volume":"21","author":[{"given":"Mohamed","family":"Saeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Kuete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onat","family":"Kadioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"B\u00f6rtzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry Johannes","family":"Greten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2014.07.011_bib0005","first-page":"589","article-title":"Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay","volume":"48","author":"Alley","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2014.07.011_bib0010","doi-asserted-by":"crossref","first-page":"e21573","DOI":"10.1371\/journal.pone.0021573","article-title":"Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells","volume":"6","author":"Arora","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2014.07.011_bib0015","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2174\/156652412803833508","article-title":"Honokiol: a novel natural agent for cancer prevention and therapy","volume":"12","author":"Arora","year":"2012","journal-title":"Curr. Mol. Med."},{"issue":"Suppl 4","key":"10.1016\/j.phymed.2014.07.011_bib0020","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1634\/theoncologist.7-suppl_4-2","article-title":"Why the epidermal growth factor receptor? The rationale for cancer therapy","volume":"7","author":"Baselga","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.phymed.2014.07.011_bib0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/28101","article-title":"Three-dimensional structure of the Stat3beta homodimer bound to DNA","volume":"394","author":"Becker","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2014.07.011_bib0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00744667","article-title":"Studies on low-level MDR cells","volume":"12","author":"Belvedere","year":"1993","journal-title":"Cytotechnology"},{"key":"10.1016\/j.phymed.2014.07.011_bib0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.onc.1202314","article-title":"Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy","volume":"18","author":"Blandino","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2014.07.011_bib0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrc3342","article-title":"The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance","volume":"12","author":"Bouwman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2014.07.011_bib0360","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.282.5393.1497","article-title":"Requirement for p53 and p21 to sustain G2 arrest after DNA damage","volume":"282","author":"Bunz","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.phymed.2014.07.011_bib0045","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.3748\/wjg.v10.i23.3459","article-title":"Honokiol: a potent chemotherapy candidate for human colorectal carcinoma","volume":"10","author":"Chen","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phymed.2014.07.011_bib0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.canlet.2009.08.032","article-title":"Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress","volume":"291","author":"Chen","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2014.07.011_bib0055","first-page":"957","article-title":"Synergistic antitumor effects of liposomal honokiol combined with cisplatin in colon cancer models","volume":"2","author":"Cheng","year":"2011","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.phymed.2014.07.011_bib0060","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/bph.12244","article-title":"Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer","volume":"169","author":"Curtin","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phymed.2014.07.011_bib0065","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phymed.2014.07.011_bib0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1566524013364194","article-title":"The human ATP-binding cassette transporter genes: from the bench to the bedside","volume":"1","author":"Efferth","year":"2001","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.phymed.2014.07.011_bib0075","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/sj.leu.2400669","article-title":"Apoptosis and resistance to daunorubicin in human leukemic cells","volume":"11","author":"Efferth","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.phymed.2014.07.011_bib0080","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0006-2952(03)00341-1","article-title":"Identification of gene expression profiles predicting tumor cell response to l-alanosine","volume":"66","author":"Efferth","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2014.07.011_bib0085","first-page":"165","article-title":"Impact of viral oncogenesis on responses to anti-cancer drugs and irradiation","volume":"11","author":"Efferth","year":"2000","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.phymed.2014.07.011_bib0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4172\/2161-1009.1000e128","article-title":"Autophagy by natural products in cancer cells","volume":"1","author":"Efferth","year":"2012","journal-title":"Biochem. Anal. Biochem."},{"key":"10.1016\/j.phymed.2014.07.011_bib0095","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/138945011793591626","article-title":"Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy","volume":"12","author":"Efferth","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.phymed.2014.07.011_bib0100","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.phymed.2011.06.008","article-title":"Cytotoxic activity of secondary metabolites derived from Artemisia annua L towards cancer cells in comparison to its designated active constituent artemisinin","volume":"18","author":"Efferth","year":"2011","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2014.07.011_bib0105","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1158\/1078-0432.CCR-07-4525","article-title":"Prediction of broad spectrum resistance of tumors towards anticancer drugs","volume":"14","author":"Efferth","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2014.07.011_bib0110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/mol.64.2.382","article-title":"Molecular modes of action of artesunate in tumor cell lines","volume":"64","author":"Efferth","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phymed.2014.07.011_bib0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2005.02.005","article-title":"Pharmacogenetics for individualized cancer chemotherapy","volume":"107","author":"Efferth","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2014.07.011_bib0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00001622-199701000-00013","article-title":"Role of oncogenes in resistance and killing by cancer therapeutic agents","volume":"9","author":"el-Deiry","year":"1997","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.phymed.2014.07.011_bib0125","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.1038\/sj.onc.1206949","article-title":"The role of p53 in chemosensitivity and radiosensitivity","volume":"22","author":"El-Deiry","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2014.07.011_bib0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-6147(00)01865-4","article-title":"Pharmacological inhibitors of MAPK pathways","volume":"23","author":"English","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phymed.2014.07.011_bib0135","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0076-6879(03)74020-8","article-title":"Modeller: generation and refinement of homology-based protein structure models","volume":"374","author":"Fiser","year":"2003","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.phymed.2014.07.011_bib0140","first-page":"237","article-title":"Chemotherapy-induced resistance by ATP-binding cassette transporter genes","volume":"1775","author":"Gillet","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phymed.2014.07.011_bib0145","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1158\/0008-5472.CAN-04-1978","article-title":"Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes","volume":"64","author":"Gillet","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2014.07.011_bib0150","doi-asserted-by":"crossref","first-page":"G929","DOI":"10.1152\/ajpgi.00159.2011","article-title":"Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects","volume":"301","author":"He","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.phymed.2014.07.011_bib0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00048059","article-title":"Apoptosis induced by anticancer drugs","volume":"11","author":"Hickman","year":"1992","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.phymed.2014.07.011_bib0160","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1745-7254.2005.00164.x","article-title":"Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin","volume":"26","author":"Hu","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phymed.2014.07.011_bib0165","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3858\/emm.2008.40.6.617","article-title":"Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity","volume":"40","author":"Hu","year":"2008","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phymed.2014.07.011_bib0365","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1074\/jbc.272.5.2927","article-title":"The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling","volume":"272","author":"Huang","year":"1997","journal-title":"J Biol Chem."},{"key":"10.1016\/j.phymed.2014.07.011_bib0170","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1471-2407-8-242","article-title":"Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model","volume":"8","author":"Jiang","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.phymed.2014.07.011_bib0175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1517\/13543776.2014.877445","article-title":"Apoptosis-inducing agents: a patent review (2010\u20132013)","volume":"24","author":"Kamal","year":"2014","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.phymed.2014.07.011_bib0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/187152013804487263","article-title":"Cytoskeletal alterations that confer resistance to anti-tubulin chemotherapeutics","volume":"13","author":"Kanakkanthara","year":"2013","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.phymed.2014.07.011_bib0185","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrc2803","article-title":"Microtubules and resistance to tubulin-binding agents","volume":"10","author":"Kavallaris","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2014.07.011_bib0190","first-page":"6793","article-title":"Susceptibility of multidrug-resistant leukemia cell lines to human interleukin 2-activated killer cells","volume":"50","author":"Kimmig","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2014.07.011_bib0195","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc1692","article-title":"The role of autophagy in cancer development and response to therapy","volume":"5","author":"Kondo","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2014.07.011_bib0200","first-page":"608","article-title":"Molecular determinants of cancer cell sensitivity and resistance towards the sesquiterpene farnesol","volume":"68","author":"Kuete","year":"2013","journal-title":"Pharmazie"},{"key":"10.1016\/j.phymed.2014.07.011_bib0205","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1089\/ars.2009.2692","article-title":"Adaptation to oxidative stress, chemoresistance, and cell survival","volume":"11","author":"Landriscina","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phymed.2014.07.011_bib0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","article-title":"Cancer. p53, guardian of the genome","volume":"358","author":"Lane","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2014.07.011_bib0215","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1158\/1078-0432.CCR-10-0333","article-title":"Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors","volume":"16","author":"Leeman-Neill","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2014.07.011_bib0220","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/neuonc\/nor217","article-title":"Honokiol traverses the blood-brain barrier and induces apoptosis of neuroblastoma cells via an intrinsic bax-mitochondrion-cytochrome c-caspase protease pathway","volume":"14","author":"Lin","year":"2012","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.phymed.2014.07.011_bib0225","first-page":"1","article-title":"EGFR-mediated cell cycle regulation","volume":"22","author":"Lui","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phymed.2014.07.011_bib0230","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/j.1875-9114.1993.tb02695.x","article-title":"Molecular targets in oncology: implications of the multidrug resistance gene","volume":"13","author":"Lum","year":"1993","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.phymed.2014.07.011_bib0235","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.phymed.2014.07.011_bib0240","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1089\/ars.2010.3383","article-title":"Sense and sensitivity: FOXO and ROS in cancer development and treatment","volume":"14","author":"Myatt","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phymed.2014.07.011_bib0245","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","author":"O\u2019Brien","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.phymed.2014.07.011_bib0250","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2008.11.029","article-title":"Down-regulation of c-Src\/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells","volume":"277","author":"Park","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2014.07.011_bib0255","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/BJ20121513","article-title":"Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain","volume":"448","author":"Park","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.phymed.2014.07.011_bib0260","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jnci\/81.14.1088","article-title":"Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm","volume":"81","author":"Paull","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phymed.2014.07.011_bib0265","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drup.2012.03.002","article-title":"Collateral sensitivity as a strategy against cancer multidrug resistance","volume":"15","author":"Pluchino","year":"2012","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.phymed.2014.07.011_bib0270","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.bmcl.2009.01.002","article-title":"Aminofurazans as potent inhibitors of AKT kinase","volume":"19","author":"Rouse","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phymed.2014.07.011_bib0275","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/jnci\/82.13.1113","article-title":"Comparison of in vitro anticancer-drug screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines","volume":"82","author":"Rubinstein","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phymed.2014.07.011_bib0280","series-title":"Tumor Cell Resistance to Apoptosis by Cytotoxic Drugs and Reversal of Resistance by Targeted Sensitizing Cells","first-page":"187","article-title":"Collateral sensitivity in drug-resistant tumor cells","author":"Saeed","year":"2013"},{"key":"10.1016\/j.phymed.2014.07.011_bib0285","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.phymed.2014.01.006","article-title":"The lignan, (\u2212)-sesamin reveals cytotoxicity toward cancer cells: pharmacogenomic determination of genes associated with sensitivity or resistance","volume":"21","author":"Saeed","year":"2014","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2014.07.011_bib0290","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/73439","article-title":"A gene expression database for the molecular pharmacology of cancer","volume":"24","author":"Scherf","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phymed.2014.07.011_bib0295","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1073\/pnas.0609757104","article-title":"Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity","volume":"104","author":"Siddiquee","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phymed.2014.07.011_bib0300","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4161\/epi.23078","article-title":"Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo","volume":"8","author":"Singh","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.phymed.2014.07.011_bib0305","doi-asserted-by":"crossref","first-page":"10787","DOI":"10.1073\/pnas.191368598","article-title":"Chemosensitivity prediction by transcriptional profiling","volume":"98","author":"Staunton","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phymed.2014.07.011_bib0310","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/bse0500209","article-title":"The controversial role of ABC transporters in clinical oncology","volume":"50","author":"Tamaki","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.phymed.2014.07.011_bib0315","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3892\/ijo.2012.1739","article-title":"Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death","volume":"42","author":"Tian","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.phymed.2014.07.011_bib0320","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrm3737","article-title":"Regulated necrosis: the expanding network of non-apoptotic cell death pathways","volume":"15","author":"Vanden Berghe","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phymed.2014.07.011_bib0325","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0960-894X(02)00992-7","article-title":"Inhibition of mast cell leukotriene release by thiourea derivatives","volume":"13","author":"Venkatachalam","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phymed.2014.07.011_bib0330","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/15376511003758831","article-title":"Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells","volume":"20","author":"Wang","year":"2010","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.phymed.2014.07.011_bib0335","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/jnci\/89.20.1505","article-title":"Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns","volume":"89","author":"Wosikowski","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phymed.2014.07.011_bib0340","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12122","article-title":"mTOR kinase structure, mechanism and regulation","volume":"497","author":"Yang","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2014.07.011_bib0345","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.phymed.2014.07.011_bib0350","first-page":"31","article-title":"Molecular docking studies of myxobacterial disorazoles and tubulysins to tubulin","volume":"3","author":"Zeino","year":"2013","journal-title":"J. Biosci. Med."},{"key":"10.1016\/j.phymed.2014.07.011_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2006.09.065","article-title":"Honokiol up-regulates prostacyclin synthease protein expression and inhibits endothelial cell apoptosis","volume":"554","author":"Zhang","year":"2007","journal-title":"Eur. J. Pharmacol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711314002979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711314002979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T00:53:49Z","timestamp":1717289629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711314002979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0944711314002979"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2014.07.011","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2014.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}